Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Optimising the collection of female genital tract fluid for cytokine analysis in pregnant women.

Short CS, Quinlan R, Bennett P, Shattock RJ, Taylor GP.

J Immunol Methods. 2018 Jul;458:15-20. doi: 10.1016/j.jim.2018.03.014. Epub 2018 Apr 3.

2.

Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.

Archary D, Liebenberg LJ, Werner L, Tulsi S, Majola N, Naicker N, Dlamini S, Hope TJ, Samsunder N, Abdool Karim SS, Morris L, Passmore JA, Garrett NJ.

PLoS One. 2015 Jul 6;10(7):e0131906. doi: 10.1371/journal.pone.0131906. eCollection 2015.

3.

Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.

Sha BE, D'Amico RD, Landay AL, Spear GT, Massad LS, Rydman RJ, Warner NA, Padnick J, Ackatz L, Charles LA, Benson CA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):161-8.

PMID:
9390567
4.

Patterns of Systemic and Cervicovaginal Fluid Inflammatory Cytokines throughout Pregnancy.

Ashford KB, Chavan N, Ebersole JL, Wiggins AT, Sharma S, McCubbin A, Barnett J, O'Brien J.

Am J Perinatol. 2018 Apr;35(5):455-462. doi: 10.1055/s-0037-1608677. Epub 2017 Nov 13.

5.
6.

The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Hughes BL, Dutt R, Raker C, Barthelemy M, Rossoll RM, Ramratnam B, Wira CR, Cu-Uvin S.

Am J Obstet Gynecol. 2016 Dec;215(6):748.e1-748.e12. doi: 10.1016/j.ajog.2016.06.057. Epub 2016 Jul 5.

7.

Evaluation of the cervicovaginal environment in asymptomatic Human T-cell lymphotropic virus type 1 infected women.

Firmino AA, Martins ALL, Gois LL, Paixão TS, Batista EDS, Galvão-Castro B, Grassi MFR.

Braz J Infect Dis. 2019 Jan - Feb;23(1):27-33. doi: 10.1016/j.bjid.2019.02.001. Epub 2019 Mar 6.

8.

Optimization of the weck-Cel collection method for quantitation of cytokines in mucosal secretions.

Rohan LC, Edwards RP, Kelly LA, Colenello KA, Bowman FP, Crowley-Nowick PA.

Clin Diagn Lab Immunol. 2000 Jan;7(1):45-8.

9.

Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery.

Kalinka J, Sobala W, Wasiela M, Brzezińska-Błaszczyk E.

Am J Reprod Immunol. 2005 Aug;54(2):70-6.

PMID:
16105098
10.

Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal sampling.

Jaumdally SZ, Masson L, Jones HE, Dabee S, Hoover DR, Gamieldien H, Langwenya N, Myer L, Todd CS, Passmore JS.

Sci Rep. 2018 Aug 15;8(1):12203. doi: 10.1038/s41598-018-30663-8.

11.

Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology.

Inic-Kanada A, Nussbaumer A, Montanaro J, Belij S, Schlacher S, Stein E, Bintner N, Merio M, Zlabinger GJ, Barisani-Asenbauer T.

Mol Vis. 2012;18:2717-25. Epub 2012 Nov 16.

12.

The association between maternal cervicovaginal proinflammatory cytokines concentrations during pregnancy and subsequent early-onset neonatal infection.

Kalinka J, Krajewski P, Sobala W, Wasiela M, Brzezińska-Błaszczyk E.

J Perinat Med. 2006;34(5):371-7.

PMID:
16965223
13.

Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum.

Eke AC, Chakhtoura N, Kashuba A, Best BM, Sykes C, Wang J, Stek AM, Smith E, Calabrese S, Capparelli EV, Mirochnick M; IMPAACT P1026s Protocol Team.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):308-313. doi: 10.1097/QAI.0000000000001677.

14.

Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study.

Walter J, Fraga L, Orin MJ, Decker WD, Gipps T, Stek A, Aldrovandi GM.

BMC Infect Dis. 2011 Sep 30;11:263. doi: 10.1186/1471-2334-11-263.

15.

Genital inflammation and the risk of HIV acquisition in women.

Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS.

Clin Infect Dis. 2015 Jul 15;61(2):260-9. doi: 10.1093/cid/civ298. Epub 2015 Apr 21.

16.

Microbiological characteristics and inflammatory cytokines associated with preterm labor.

Discacciati MG, Simoes JA, Silva MG, Marconi C, Brolazo E, Costa ML, Cecatti JG.

Arch Gynecol Obstet. 2011 Mar;283(3):501-8. doi: 10.1007/s00404-010-1427-z. Epub 2010 Mar 18.

PMID:
20237933
17.

Applying SWATH Mass Spectrometry to Investigate Human Cervicovaginal Fluid During the Menstrual Cycle.

Vaswani K, Ashman K, Reed S, Salomon C, Sarker S, Arraztoa JA, Pérez-Sepúlveda A, Illanes SE, Kvaskoff D, Mitchell MD, Rice GE.

Biol Reprod. 2015 Aug;93(2):39. doi: 10.1095/biolreprod.115.128231. Epub 2015 Jun 24.

PMID:
26108790
18.

Cervical and vaginal cytokine determinations in pregnant women: methodologic issues.

Gennaro S, Raftery N, Campbell D, Shults J.

Biol Res Nurs. 2008 Jan;9(3):215-22.

PMID:
18077774
19.

Pregnancy-induced changes in immune protection of the genital tract: defining normal.

Anderson BL, Mendez-Figueroa H, Dahlke JD, Raker C, Hillier SL, Cu-Uvin S.

Am J Obstet Gynecol. 2013 Apr;208(4):321.e1-9. doi: 10.1016/j.ajog.2013.01.014. Epub 2013 Jan 10.

20.

Cervical fluid cytokines in pregnant women: Relation to vaginal wet mount findings and polymorphonuclear leukocyte counts.

Nenadić DB, Pavlović MD.

Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):165-70. doi: 10.1016/j.ejogrb.2008.02.020. Epub 2008 Apr 11.

PMID:
18406509

Supplemental Content

Support Center